NLS Pharmaceutics AG


0.14 (USD) • At close April 15, 2024
Bedrijfsnaam NLS Pharmaceutics AG
Symbool NLSP
Munteenheid USD
Prijs 0.142
Beurswaarde 5,598,193
Dividendpercentage 0%
52-weken bereik 0.132 - 1.58
Industrie Biotechnology
Sector Healthcare
CEO Mr. Alexander Zwyer M.B.A.

An error occurred while fetching data.

Over NLS Pharmaceutics AG

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention

Vergelijkbare Aandelen

CNS Pharmaceuticals, Inc. logo

CNS Pharmaceuticals, Inc.


0.244 USD

Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp.


1.99 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)